Schedule 13D ownership disclosure
Checkmate Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 162818108
Event date: 2022-05-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,103,417
- Percent of class
- Unavailable
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000941560-22-000006
- Form type
- SC 13D
- Filer
- Checkmate Pharmaceuticals, Inc.
- CIK
- CIK 1651431
- Filed
- Jun 03, 2022
- Reporting period
- May 25, 2022
- Description
- Schedule 13D beneficial ownership